{"id":"W4400018844","doi":"10.1182/bloodadvances.2024013451","title":"Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; University of British Columbia; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Cancer Moonshot; National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Moonshot Research and Development Program; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Amgen; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Myelofibrosis; Transplantation; Gastroenterology; Surgery; Hematopoietic cell; Bone marrow; Haematopoiesis; Stem cell","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003035177,0.0004682743,0.0004528957,0.001250775,0.0005682749,0.001369876,0.0009413854,0.000610583,0.003148846],"category_scores_gemma":[0.00400488,0.0003187496,0.0008693041,0.0016539,0.0005090158,0.0007875042,0.001338257,0.00114649,0.000469972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006183364,"about_ca_system_score_gemma":0.0006858021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002288111,"about_ca_topic_score_gemma":0.002321665,"domain_scores_codex":[0.9986089,0.0004320353,0.0001580805,0.0003095017,0.0002341992,0.0002573117],"domain_scores_gemma":[0.99646,0.000375813,0.00188697,0.0003818714,0.0002374449,0.0006579169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007753559,0.00009977832,0.9970853,0.00003577449,0.0002415526,0.00006301558,0.00006040882,0.00004250032,0.0001100346,0.00006068124,0.0001794503,0.001246173],"study_design_scores_gemma":[0.0001465952,0.000474688,0.9968471,0.00006988503,0.0003513579,0.0006327127,0.0004071117,0.0002602086,0.0001311544,0.000108328,0.0005524436,0.00001843828],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979736,0.0008461989,0.00008955524,0.00005984732,0.0000132328,0.00001526465,0.0005574735,0.000002221379,0.0004426092],"genre_scores_gemma":[0.9988876,0.0002042844,0.00005824881,0.00005772054,0.00003114277,0.00001302402,0.0006387467,0.000003181789,0.0001061231],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003148846,"threshold_uncertainty_score":0.01605171,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01013457935254995,"score_gpt":0.2985045083005212,"score_spread":0.2883699289479712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}